Minimally invasive nitinol-stent solution for benign prostatic hyperplasia
| Date | Round | Amount |
|---|---|---|
| Aug 2025 | Series B Dublin medtech ProVerum closed an USD 80m Series B led by MVM Partners, with new investors OrbiMed and ISIF joining alongside Enterprise Ireland and Lightstone Ventures. | $80M |
| Jan 2022 | Series A Dublin medtech ProVerum raised a €30m Series A co-led by Gilde Healthcare Partners and Lightstone Ventures for its prostate-treatment device. | $32.4M |
| Oct 2021 | Grant ProVerum was selected for EIC Accelerator grant-and-equity funding as one of five Enterprise Ireland-backed Irish companies sharing more than €20.5m. | — |